DDT insecticide increases risk of preterm birth

July 12, 2001

Exposure of pregnant women to DDT, the insecticide effective in malaria control, is strongly linked to an increase in preterm birth, conclude authors of a study in this week's issue of THE LANCET.

DDT was banned or restricted in industrialised countries in the 1970s but in many countries it is still widely used against malaria-transmitting mosquitoes. The concentrations to which human beings are exposed during mosquito control are thought to have no serious toxic effects, and the benefits of the reduction in malaria are substantial. The metabolite DDE has previously been linked to preterm births in small but inconclusive studies.

Basing a study on the US Collaborative Perinatal Project, Matthew Longnecker and colleagues from the National Institute of Environmental Health Sciences, USA, selected a subset of more than 44 000 eligible children born between 1959 and 1966 and measured the DDE concentration in their mothers' blood samples stored during pregnancy. Complete data were available for 2380 children, of whom 361 were born preterm (before 37 weeks' gestation) and 221 were small-for-gestational age (were in the lowest 10% weight for each week of pregnancy).

The average maternal DDE concentration was 25 μg per litre, much higher than current US concentrations. The risk of preterm birth or babies small for gestational age rose with increasing concentrations of blood DDE.

Matthew Longnecker comments: "Our findings suggest that DDT use increases preterm births, and, by inference, infant mortality. Benefits of vector control with DDT might need to be reassessed in the context of this adverse effect on human beings and the availability of alternative methods of vector management."
-end-
Contact: Dr Matthew P Longnecker, Epidemiology Branch, National Institute of Environmental Health Sciences, P O Box 12233 MDA3-05, Research Triangle Park, NC 27709, USA; T) +1 919 541 5118; F) +1 919 541 2511; E) longnecker@niehs.nih.gov

The article is available at http://www.eurekalert.org/jrnls/lance/pdfs/110.pdf.

Lancet

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.